Navigation Links
Trudeau Institute announces latest discovery in vaccine development

Saranac Lake, N.Y. New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections. This new data will be published in the January 2012 issue of the journal Nature Immunology (Vol. 13, pp. 44-50). The paper, "iNKT cells direct B cell responses to cognate lipid antigen in an interleukin 21-dependent manner," is now available through Advance Online Publication (AOP) on Nature Immunology's website at

About the new findings

Effective vaccines train our bodies to recognize harmful microbes (such as viruses, bacteria and parasites) and typically contain disabled microbes, or even just components of microbes called antigens. Vaccination tricks our bodies into thinking we have been infected by the harmful microbe, triggering an immune response. Ideally, the vaccine produces a long-lived "memory" immune response to the microbe's antigens. This memory allows our bodies to respond more quickly and effectively if we ever become infected by the harmful microbe.

Most human vaccines contain adjuvants -- substances added to the vaccine to improve immune response to the antigens. Adjuvants increase the strength of the immune response and also allow for smaller amounts of antigens to be used in vaccine production.

Immune response to antigens results in the production of antibodies, which are a secreted product of B cells. Antibodies attach to antigens and help our bodies eliminate harmful microbes. Some T cells can help B cells make antibodies. Dr. Leadbetter previously discovered that natural killer T (NKT) cells, a special population of T cells, can help B cells make antibodies. NKT cells are special because they recognize lipid (fat) antigens. In contrast, most helper T cells recognize protein antigens. Because many harmful microbes produce unique lipids, Dr. Leadbetter hypothesized that directing NKT cells to help B cells could provide a new way to induce antibodies against harmful microbes, which would complement existing vaccine technologies.

Dr. Leadbetter's new studies advance her hypothesis that lipid molecules may serve as promising vaccine components. The studies demonstrate that NKT cells can help B cells produce antibodies that recognize lipids, but this does not result in long-lived memory immune responses to the lipid antigens. Second, the studies demonstrate that the lipids, when used as adjuvants to enhance immune responses to more conventional protein antigens, induce memory immune responses against the protein target without inducing a memory response to the lipid itself. Together, these findings suggest a single lipid adjuvant could be used multiple times without losing its effect. The new research also characterizes how NKT cells help B cells produce antibodies when lipids are used as a vaccine adjuvant.

Lipids may become an important new class of adjuvants not only because of their intrinsic properties but also because of their capacity to activate NKT cells. According to Dr. Leadbetter, "These cells are really fascinating because they have both innate and adaptive immune cell properties. In other words, they act rapidly, but also specifically. NKT cell activation by certain lipids enhances the activation of other immune cells, thus acting as the body's natural adjuvant."

About Dr. Elizabeth Leadbetter

Dr. Leadbetter earned a B.S. with highest honors from Bates College (Lewiston, Maine) in 1993 and worked for ImmuLogic Pharmaceutical Corporation (Waltham, Mass.) before receiving her Ph.D. in microbiology/immunology from Boston University School of Medicine in 2002. She was a postdoctoral fellow and then an instructor in the Division of Rheumatology with Dr. Michael B. Brenner at Brigham and Women's Hospital/Harvard Medical School until 2009, when she joined the Trudeau Institute as an Assistant Member of the faculty.

Dr. Leadbetter's research, which is funded by the Trudeau Institute, was performed with current and former Trudeau faculty members, including Dr. Irah King, Michael Tighe, John Dibble, Dr. Anne Fortier, and Dr. Markus Mohrs. Dr. Michael Brenner, of Brigham & Women's Hospital, and Dr. Gurdyal S. Besra and Dr. Natacha Verapeen from University of Birmingham (UK) were also important contributors to these studies.


Contact: Kim Godreau
518-891-3080 x561
Trudeau Institute

Related medicine news :

1. Trudeau Institute reports new approach to treating Listeria infections
2. Huntsman Cancer Institute awarded top honors as cancer imaging facility
3. Van Andel Institute study may lead to better, safer drug for diabetes
4. Jeopardy! winnings spur IBM and Scripps Research Institute collaboration to fight against malaria
5. Mass. General Cancer Center and Vall dHebron Institute of Oncology biomarker alliance
6. US institute wraps up data collection in Russian Mars 520-day mission simulation
7. Scott & White Cancer Research Institute receives $3.5 million grant
8. Researchers get $3 million National Institutes of Health grant for mathematical models of prostate cancer aggressiveness
9. UNCs Rubinow elected to Institute of Medicine
10. Regenstrief Institute president to receive national recognition
11. AMIA honors Regenstrief Institutes President and CEO with 2011 Morris F. Collen Award
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... is one of a select few plastic surgeons in the New York City ... , SculpSure™ is the world’s first heat-induced laser treatment for fat loss in ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... ), a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, ... the Microsoft Partner Program with competencies in the Application Development, demonstrating a ...
(Date:11/30/2015)... ... November 30, 2015 , ... Workstation solutions provider ... 30 HealthPostures’ dealers located throughout the United States, is OneStop Ergonomics. The addition ... industrial, manufacturing and government workers and organizational leaders that are introduced to innovative ...
(Date:11/30/2015)... ... November 30, 2015 , ... CTI Group (Holdings) Inc. ... organizations through communication analytics, announced today that their Proteus® VoIP QMS solution now ... quality. , Proteus® VoIP QMS (Quality Management System) does this by ...
(Date:11/29/2015)... (PRWEB) , ... November 30, 2015 , ... The Cyber Monday deal is a deep ... is the right time to get gifts for the skin care lover in your circle. ... filled with serums . This year, the 3 serums are staples: Collagen, Retinol and Hyaluronic ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Belgium , Nov. 30, 2015   ... focused on developing blood-based diagnostic tests for a broad range ... will present at the LD Micro Conference, which will be ... CA. Attending from VolitionRx will be David ... Powell , Vice President of Investor Relations. ® ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, ... acquiring and developing innovative therapies for ear, nose, and ... Keith A. Katkin as chairman of the company,s ... chief executive officer for OticPharma, Ltd.  "Keith brings a ... he will be able to share this experience and ...
(Date:11/29/2015)... Nov. 29, 2015   Royal Philips  (NYSE: PHG, ... solutions at the 2015 Radiological Society of North America ... McCormick Place in Chicago . Visitors ... the company,s broad portfolio of integrated Diagnostic Imaging, Clinical ... increase clinical performance, improve workflow and create a superior ...
Breaking Medicine Technology: